Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apyron Technologies was an advanced materials company focused on the development of catalytic and adsorbent technologies for environmental and life science applications. The company specialized in the removal of contaminants such as arsenic, lead, and other heavy metals from water supplies using its proprietary Aqua-Bind and XSORBX technologies. While primarily known for water purification, Apyron's materials were also explored for use in medical devices and pharmaceutical processing to ensure high-purity environments. The company was acquired by Molycorp in 2010 to integrate its specialized filtration technologies into a broader rare-earth materials portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apyron.